Problems associated with clinical trials of Ayurvedic medicines

Abstract

Herbal drugs have been used since ancient times as medicines for the treatment of various diseases. Especially in countries like India many of herbal drugs and formulations are used in different practices of treatment like Ayurveda, Siddha and Unani. It is estimated that about 25% of all modern medicines are directly or indirectly derived from plants sources. The contribution of developing countries in global herbal business is very poor due to lack of quality control and standardization measures. There is lack of common standards and appropriate methods for evaluating Traditional Medicine to ensure the safety, efficacy and quality control. This indicates the importance and necessity to develop a standard operational procedure for the standardization of herbal drugs and formulations. Benchmarking the evaluation protocols including both quality control and quality assurance of herbal drugs would play a major role in providing highly reliable and effective herbals drugs and to attract international trade, thus generating revenue. The article highlights various problems being faced by developing countries and suggests a unique approach for the preparation of SOP/guidelines for the standardization of all herbal based formulations, also there is a need for systematic clinical trials of traditional plant based medicines to enhance global acceptance.

Pharmacognosy of Enicostemma littorale: A review

“…E. littorale is a good source of iron, potassium, sodium, calcium, magnesium, silica, chloride, sulphate, phosphate and vitamins B and C [4] . According to the World Health Organization (WHO), herbal medicines serve the health needs of about 80 % of the world's population, especially for millions of people in the vast rural areas of developing countries [5] .…”

How does traditional home-gardens support ethnomedicinal values in Kumaun Himalayan Bhabhar belt, India?

“…Figure 7 indicated that most utilized plant parts were leaves (34%) followed by fruits (19%) while the least used was bark (only 2%). A similar kind of study was conducted by Sharma et al (2010) in Zangelanlo district, Northeast Iran in which among the medicinal plants parts; leaf (25%) was used in majority of cases. This was followed by fruits (19%), roots (15%), seeds (12%) and bark (2%).…”

Exploring Nanotechnologies for the Effective Therapy of Malaria Using Plant-Based Medicines

“…The differences in content, quantity and quality of some herbal products could be due to different extraction, processing and manufacturing methods utilised by manufacturers [87]. Also, there are reports on insufficient standardization and quality control of the herbal drugs used in clinical trials which may be due to different dosages of herbal medicines being used, improper randomization and use of insufficient number of patients, difficulty in establishing appropriate placebos (as a result organoleptic properties like taste and aroma) as well as variations in treatment durations [88]. All these factors make standardization difficult.…”